excluded period(s) [Regulatives / Guidelines]

posted by rajasekharkakarla – India, 2019-09-20 05:57  – Posting: # 20630
Views: 2,041

Hi Helmut sir!

» Since according to the FDA a partial replicate has to be analyzed by SAS Proc GLM (or similar) IMHO all data of the subject will be dropped from the analysis (even if you observe a pre-dose concentration in just one period).

if we get the Swr less than 0.294 then we need to go for ABE approach in that can can we include those subjects in ABE calculation if subject completed 1 test and 1 reference treatment period.

what about in case of fully replicated designs, if we got the 5 % cmax in 4th period with 2 reference periods completed or one Test and Reference treatment period completed.

please help me..

Complete thread:

Activity
 Admin contact
20,793 posts in 4,353 threads, 1,445 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: 09:57 UTC (Europe/Vienna)

In God we trust;
all others must bring data.    W. Edwards Deming

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5